Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

LEGN

Legend Biotech Corp ADR

Mar 13 • 04:00PM ET

38.05

Dollar change -0.19
Percentage change -0.50	%

Healthcare • Biotechnology • USA • NASD

Peers: GILD CRSP BMY BLUE ALLO EDIT FATE CLLS NTLA SGMO

| Held by: IBB IEMG EEMV MCHI EEM IXUS SPEM GNOM CANC ACWV

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.98	Insider Own	1.37%	Shs Outstand	183.45M	Perf Week	11.32%
Market Cap	6.98B	Forward P/E	73.83	EPS next Y	0.52	Insider Trans	0.00%	Shs Float	180.94M	Perf Month	9.88%
Income	-177.03M	PEG	-	EPS next Q	-0.20	Inst Own	53.49%	Short Float	7.24%	Perf Quarter	-8.60%
Sales	627.24M	P/S	11.13	EPS this Y	25.46%	Inst Trans	9.75%	Short Ratio	10.22	Perf Half Y	-23.59%
Book/sh	6.08	P/B	6.25	EPS next Y	244.04%	ROA	-10.06%	Short Interest	13.10M	Perf Year	-41.63%
Cash/sh	6.12	P/C	6.22	EPS next 5Y	-	ROE	-15.45%	52W Range	30.17 - 69.24	Perf YTD	16.93%
Dividend Est.	-	P/FCF	-	EPS past 5Y	0.79%	ROI	-12.77%	52W High	-45.05%	Beta	0.14
Dividend TTM	-	Quick Ratio	4.54	Sales past 5Y	132.21%	Gross Margin	62.60%	52W Low	26.12%	ATR (14)	1.91
Dividend Ex-Date	-	Current Ratio	4.62	EPS Y/Y TTM	67.22%	Oper. Margin	-48.65%	RSI (14)	57.06	Volatility	5.79% 5.06%
Employees	1826	Debt/Eq	0.34	Sales Y/Y TTM	119.97%	Profit Margin	-28.22%	Recom	1.24	Target Price	78.76
Option/Short	Yes / Yes	LT Debt/Eq	0.33	EPS Q/Q	116.39%	Payout	-	Rel Volume	1.23	Prev Close	38.24
Sales Surprise	4.27%	EPS Surprise	128.29%	Sales Q/Q	134.73%	Earnings	Mar 11 BMO	Avg Volume	1.28M	Price	38.05
SMA20	4.35%	SMA50	6.83%	SMA200	-13.61%	Trades		Volume	1,582,450	Change	-0.50%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-08-24	Initiated	Redburn Atlantic	Buy	$86
Jun-17-24	Initiated	Truist	Buy	$88
May-24-24	Reiterated	H.C. Wainwright	Buy	$86 → $73
May-23-24	Initiated	Deutsche Bank	Buy	$60
Apr-17-24	Upgrade	Scotiabank	Sector Perform → Sector Outperform	$65
Apr-03-24	Initiated	Cantor Fitzgerald	Overweight	$82
Mar-13-24	Initiated	Raymond James	Outperform	$86
Dec-19-23	Initiated	Scotiabank	Sector Perform
Nov-06-23	Initiated	Goldman	Buy	$90.09
May-25-23	Initiated	William Blair	Mkt Perform	$64
May-22-23	Initiated	Daiwa Securities	Buy
Mar-29-23	Initiated	H.C. Wainwright	Buy	$66
Mar-24-23	Initiated	RBC Capital Mkts	Outperform	$73
Dec-06-22	Initiated	UBS	Buy	$66
Nov-02-22	Initiated	Evercore ISI	Outperform
Nov-01-22	Initiated	Cowen	Outperform
Oct-31-22	Initiated	Guggenheim	Neutral
Jun-17-22	Initiated	BMO Capital Markets	Outperform	$77
Mar-15-22	Initiated	Barclays	Overweight	$53
Jan-31-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$51

Show Previous Ratings

Mar-12-25 03:02AM	Legend Biotech Corp (LEGN) Q4 2024 Earnings Call Highlights: Record CARVYKTI Sales and ... (GuruFocus.com)
01:34AM	Q4 2024 Legend Biotech Corp Earnings Call (Thomson Reuters StreetEvents)
Mar-11-25 09:30AM	Compared to Estimates, Legend Biotech (LEGN) Q4 Earnings: A Look at Key Metrics (Zacks) +9.29%
07:00AM	Legend Biotech Reports Fourth Quarter and Full Year 2024 Results and Recent Highlights (GlobeNewswire)
Feb-25-25 08:00AM	Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 Results (GlobeNewswire)
01:29PM	Loading…
Feb-23-25 01:29PM	Why Legend Biotech Corporation (LEGN) is the Most Oversold Pharma Stock to Buy According to Analysts (Insider Monkey)
Feb-21-25 09:43AM	Market Concerns Put Pressure on Legend Biotech Corporation (LEGN) Shares (Insider Monkey)
Feb-20-25 12:18PM	Legend Biotech Corporation (LEGN): One of the Most Oversold Healthcare Stocks to Buy Now (Insider Monkey)
Feb-13-25 02:06PM	Is Legend Biotech (LEGN) the Best Mid-Cap Growth Stock to Buy According to Analysts? (Insider Monkey)
Feb-08-25 09:29AM	Why Legend Biotech Corporation (LEGN) Is Among the Best Healthcare Stocks To Buy According to Analysts (Insider Monkey)
Jan-30-25 05:01PM	Heres Why Legend Biotech Corporation (LEGN) Will Double in 2025 (Insider Monkey)
Jan-17-25 11:04AM	Legend Biotech Corporation (LEGN): The Biotech Stock with Biggest Upside Potential (Insider Monkey)
Dec-19-24 08:01AM	Legend Biotech to Present at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-11-24 07:22AM	Legend Biotechs CARVYKTI® Boosts Myeloma Treatment Success (TipRanks) -5.44%
Dec-09-24 07:35PM	CARVYKTI Significantly Improved Minimal Residual Disease Negativity Compared to Standard of Care for Patients with Relapsed or Refractory Multiple Myeloma (GlobeNewswire) -8.96%
04:22PM	Loading…
04:22PM	Arcellx And Legend Bio Trade Jabs In Multiple Myeloma. But Only One Pulls Ahead. (Investor's Business Daily)
Nov-27-24 10:02AM	Why Is Legend Biotech Corp. (LEGN) Among the Best Up and Coming Stocks to Buy According to Analysts? (Insider Monkey)
Nov-22-24 07:31AM	Legend Biotech Corp. (LEGN): Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts (Insider Monkey)
Nov-21-24 05:28PM	Why Is Legend Biotech Corporation (LEGN) Among the Worst Performing Biotech Stocks in 2024? (Insider Monkey)
Nov-13-24 03:28AM	Q3 2024 Legend Biotech Corp Earnings Call (Thomson Reuters StreetEvents)
02:07AM	Legend Biotech Corp (LEGN) Q3 2024 Earnings Call Highlights: CARVYKTI's Impressive Growth Amid ... (GuruFocus.com)
Nov-12-24 09:30AM	Legend Biotech (LEGN) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
07:00AM	Legend Biotech Reports Third Quarter 2024 Results and Recent Highlights (GlobeNewswire)
Nov-11-24 09:55AM	Legend Biotech (LEGN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now (Zacks)
07:04AM	Legend Biotech Corp (LEGN) Q3 2024 Earnings Report Preview: What to Look For (GuruFocus.com)
Nov-07-24 07:30AM	Legend Biotech to Host Investor Event During the 66th American Society of Hematology (ASH) Annual Meeting and Exposition (GlobeNewswire)
Nov-05-24 09:10AM	Legend Biotech to Unveil Minimal Residual Disease Data from Landmark CARTITUDE-4 Trial in Multiple Myeloma (GlobeNewswire)
Nov-04-24 07:30AM	Legend Biotech Appoints Alan Bash as President of CARVYKTI (GlobeNewswire)
Oct-24-24 09:55AM	Wall Street Analysts Believe Legend Biotech (LEGN) Could Rally 90.83%: Here's is How to Trade (Zacks)
08:00AM	Legend Biotech to Host Investor Conference Call on Third Quarter 2024 Results (GlobeNewswire)
03:45PM	Loading…
Oct-16-24 03:45PM	Is Legend Biotech Corporation (LEGN) the Most Promising Biotech Stock According to Hedge Funds? (Insider Monkey)
Oct-03-24 07:30AM	Legend Biotech to Establish New, State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia (GlobeNewswire)
Sep-30-24 04:11PM	Legend Biotech Reverses After J&J-Tied Cancer Drug Cuts Risk Of Death By 45% (Investor's Business Daily)
09:46AM	Legend Biotech Rises After J&J-Tied Cancer Drug Cuts Risk Of Death By 45% (Investor's Business Daily)
Sep-27-24 04:35PM	CARVYKTI is the First and Only Cell Therapy to Significantly Extend Overall Survival Compared to Standard of Care in Patients with Multiple Myeloma as Early as Second Line (GlobeNewswire) +5.17%
04:30PM	Legend Biotech's J&J-Partnered Drug Cut The Risk Of Death By 45% In Multiple Myeloma (Investor's Business Daily)
Sep-24-24 09:00AM	Multiply Labs Announces a Collaboration on Automating Cell Therapy Manufacturing with Legend Biotech (Business Wire)
Sep-14-24 07:22PM	Legend Biotech Corporation (LEGN): Among Hedge Funds Top Biotech Stock Picks (Insider Monkey)
Sep-12-24 03:34AM	Heres Why TimesSquare Capital Management U.S. Focus Growth Strategy Removed Legend Biotech Corporation (LEGN) from its Portfolio (Insider Monkey)
Sep-03-24 12:01PM	Matthews Emerging Markets Small Companies Fund Boosts Stake in Legend Biotech Corp (GuruFocus.com)
Aug-27-24 10:28AM	GenScript Subsidiary Legend Biotech Achieves Breakthrough with Cilta-cel Approval in China, Offering New Hope for Multiple Myeloma Patients (PR Newswire)
Aug-20-24 08:00AM	Legend Biotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference (GlobeNewswire)
Aug-09-24 07:00AM	Legend Biotech Reports Second Quarter 2024 Results and Recent Highlights (GlobeNewswire)
Aug-08-24 04:05PM	Legend Biotech Appoints Peter Salovey, Ph.D., to its Board of Directors (GlobeNewswire)
Jul-29-24 03:24PM	Is Legend Biotech Corporation (LEGN) a Good Growth Stock to Buy? (Insider Monkey)
Jul-26-24 07:00AM	Legend Biotech Announces Preliminary Results for the Six-Months Ended June 30, 2024 (GlobeNewswire)
Jul-15-24 09:17AM	Legend Biotech (LEGN) Up 12% on Reports of Takeover Bid (Zacks)
07:39AM	Legend Biotech (LEGN) Surges 12.1%: Is This an Indication of Further Gains? (Zacks)
Jul-10-24 08:00AM	Legend Biotech to Host Investor Conference Call on Second Quarter 2024 Results (GlobeNewswire)
Jul-02-24 08:00AM	Legend Biotech Announces Positive Overall Survival Results of Landmark Phase 3 CARTITUDE-4 Trial in Multiple Myeloma (GlobeNewswire)
Jun-24-24 08:13AM	Does Legend Biotech (LEGN) Have a Long Runway for Growth? (Insider Monkey)
Jun-20-24 05:26PM	Biotech Advances Propel Oncology Market to $564.5B Amid Youth Cancer Spike (PR Newswire)
Jun-03-24 04:00PM	Legend Biotech Shares Data on the Earliest Use to Date of CARVYKTI in the Treatment of Multiple Myeloma and Important Subgroup Analyses at ASCO and EHA (Business Wire)
May-29-24 08:00AM	Legend Biotech to Participate in the Jefferies Global Healthcare Conference (Business Wire)
May-23-24 05:00PM	Legend Biotech to Highlight Leadership in CAR-T Cell Therapy for Patients with Multiple Myeloma at ASCO and EHA (Business Wire) -7.28%
May-15-24 08:19AM	Legend Biotech Corporation (NASDAQ:LEGN) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-14-24 09:23AM	HC Wainwright Adjusts Price Target on Legend Biotech to $86 From $87, Keeps Buy Rating (MT Newswires)
06:54AM	RBC Adjusts Price Target on Legend Biotech to $86 From $85 on Model Updates, Maintains Outperform Rating (MT Newswires)
03:01AM	Legend Biotech Corp (LEGN) Q1 2024 Earnings Call Transcript Highlights: Soaring CARVYKTI Sales ... (GuruFocus.com)
12:20AM	Q1 2024 Legend Biotech Corp Earnings Call (Thomson Reuters StreetEvents)
May-13-24 11:53AM	LEGN Stock Earnings: Legend Biotech Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
09:24AM	Sector Update: Health Care Stocks Decline Pre-Bell Monday (MT Newswires)
08:57AM	Sector Update: Health Care (MT Newswires)
07:30AM	Legend Biotech Q1 Net Loss Narrows as Revenue Rises; Shares Rise Pre-Bell (MT Newswires)
07:00AM	Legend Biotech Reports First Quarter 2024 Results and Recent Highlights (Business Wire)
May-09-24 08:52AM	Should You Buy Legend Biotech (LEGN) Ahead of Earnings? (Zacks)
Apr-25-24 11:28AM	11 Oversold MidCap Stocks To Buy Now (Insider Monkey)
Apr-22-24 01:37PM	Legend Biotech's Carvykti Gets European Commission Approval for Treatment of Blood Cancer (MT Newswires)
01:05PM	CARVYKTI (ciltacabtagene autoleucel) Approved by the European Commission for Second-line Treatment of Patients with Relapsed and Refractory Multiple Myeloma (Business Wire)
Apr-11-24 08:00AM	Legend Biotech to Host Investor Conference Call on First Quarter 2024 Results (Business Wire)
Apr-08-24 08:48AM	Why Legend Biotech (LEGN) Stock Might be a Great Pick (Zacks)
Apr-05-24 11:36PM	U.S. FDA approves expanded use of J&J's cancer cell therapy (Reuters)
11:30PM	Legend Biotech's CARVYKTI (ciltacabtagene autoleucel) Becomes the First and Only BCMA-Targeted CAR-T Cell Therapy Approved by the FDA for Second-Line Treatment of Multiple Myeloma (Business Wire)
Apr-03-24 05:39AM	Should You Continue to Hold Legend Biotech Corporation (LEGN)? (Insider Monkey)
Mar-29-24 05:09AM	Management's Conservative Guidance Led Legend Biotech Corporation (LEGN) to Decline in Q4 (Insider Monkey)
Mar-19-24 08:30AM	Legend Biotech Announces Publication of Inaugural Environmental, Social and Governance (ESG) Report (Business Wire)
Mar-17-24 08:50AM	30 Biggest Biotechnology Companies in the World (Insider Monkey)
Mar-15-24 03:15PM	CARVYKTI (ciltacabtagene autoleucel) Receives Recommendation from the U.S. FDA Oncologic Drugs Advisory Committee for Earlier Treatment of Patients with Relapsed/Refractory Multiple Myeloma (Business Wire)
Mar-12-24 08:20AM	Legend Biotech Corporation (NASDAQ:LEGN) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-11-24 07:00AM	Legend Biotech Reports Fourth Quarter and Full Year 2023 Results and Recent Highlights (Business Wire)
Feb-23-24 07:15AM	Legend Biotech Announces Positive CHMP Opinion for CARVYKTI (ciltacabtagene autoleucel) for the Treatment of Patients with Relapsed and Lenalidomide Refractory Multiple Myeloma in Earlier Lines of Therapy (Business Wire) +7.10%
Feb-13-24 08:00AM	Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2023 Results (Business Wire)
Feb-07-24 02:41AM	Matthews Emerging Markets Small Companies Fund Bolsters Position in CarTrade Tech Ltd (GuruFocus.com)
Jan-22-24 08:34PM	UPDATE 6-US FDA seeks 'boxed warning' for CAR-T cancer therapies (Reuters) +8.17%
08:11PM	US FDA requires 'boxed warning' for CAR-T cancer therapies (Reuters)
08:05AM	Should You Expect Strong Financial Growth For Legend Biotech Corporation (LEGN)? (Insider Monkey)
Jan-03-24 08:30AM	Legend Biotech Announces Closing of License Transaction for Certain CAR-T Therapies Targeting DLL3 (Business Wire)
Jan-02-24 10:29AM	Why healthcare, biotech may be top plays for 2024: BTIG (Yahoo Finance Video)
08:30AM	Legend Biotech to Participate in the 42nd Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-26-23 06:56PM	13 High Growth Healthcare Stocks to Buy (Insider Monkey)
Dec-19-23 11:40AM	5 Most Promising Healthcare Stocks According to Analysts (Insider Monkey)
Dec-11-23 07:30PM	Patient-Reported Outcomes from the CARTITUDE-4 Study Showed Clinically Meaningful Improvements in Health-Related Quality of Life and Reductions in Multiple Myeloma Symptoms Following Treatment with CARVYKTI (ciltacabtagene autoleucel) (Business Wire)
Nov-28-23 02:51PM	FDA Looking Into All Approved CAR T Therapies on Risk of Cancer in White Blood Cells (The Wall Street Journal)
Nov-24-23 04:02PM	Legend Biotech Corporation (NASDAQ:LEGN) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-20-23 11:09PM	Q3 2023 Legend Biotech Corp Earnings Call (Thomson Reuters StreetEvents) -6.29% -5.37%
06:00AM	Legend Biotech Reports Third Quarter 2023 Results and Recent Highlights (Business Wire)
Nov-16-23 05:50AM	Looking for Stocks to Buy? Here Are the Companies Johnson & Johnson Is Betting the Most On (Motley Fool)
Nov-14-23 10:47AM	Should You Buy Legend Biotech (LEGN) Ahead of Earnings? (Zacks)
Nov-13-23 08:30AM	Legend Biotech Announces Exclusive, Global License Agreement for Certain CAR-T Therapies Targeting DLL3 (Business Wire)
07:00AM	Novartis licenses Legend cell therapy for lung cancer (BioPharma Dive)

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	SEC Form 4
Macomber Lori	Former Officer	Mar 13 '25	Proposed Sale	37.52	32,632	1,224,285	Mar 13 11:42 AM
Macomber Lori	Former Officer	Jan 10 '25	Proposed Sale	32.19	2,254	72,553	Jan 10 03:14 PM
Huang Ying	Officer	Dec 24 '24	Proposed Sale	32.45	63,061	2,046,512	Dec 26 09:59 AM
Macomber Lori	Officer	Dec 24 '24	Proposed Sale	32.45	189	6,134	Dec 26 09:48 AM
Heyman Tomas J.	Director	Dec 02 '24	Proposed Sale	43.31	4,366	189,080	Dec 02 03:08 PM
Huang Ying	Officer	Sep 25 '24	Proposed Sale	44.10	1,504	66,326	Sep 25 03:30 PM
Macomber Lori	Officer	Sep 20 '24	Proposed Sale	48.91	90,060	4,405,003	Sep 20 04:43 PM
Yau Wai Man Philip	Director	Sep 20 '24	Proposed Sale	51.04	1,946	99,324	Sep 20 10:46 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LEGN

Legend Biotech Corp ADR

Upgrade your FINVIZ experience